These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 3160461

  • 1. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
    Lockshin A, Giovanella BC, Mendoza JT, Warneke C, Stehlin JS.
    Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461
    [Abstract] [Full Text] [Related]

  • 2. [The selective toxicity of 5-hydroxymethyldeoxyuridine for the cells of human adenocarcinoma of the large intestine].
    Lockshin A, Meshcherikova VV.
    Vopr Onkol; 1989; 35(11):1327-32. PubMed ID: 2609523
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of in vitro assays for the cytotoxic effect of anticancer drugs].
    Li XT, Lin C, Li PY.
    Zhonghua Zhong Liu Za Zhi; 1986 May; 8(3):184-6. PubMed ID: 3743346
    [Abstract] [Full Text] [Related]

  • 4. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H, Tanaka M, Fukushima M, Sasaki T, Matsuda A.
    J Med Chem; 1996 Dec 06; 39(25):5005-11. PubMed ID: 8960561
    [Abstract] [Full Text] [Related]

  • 5. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
    Damon LE, Christensen S, Rochlitz C, Cadman EC.
    Anticancer Res; 1989 Dec 06; 9(6):1761-7. PubMed ID: 2534035
    [Abstract] [Full Text] [Related]

  • 6. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T, Suzuki N, Yamaguchi M, Ohshimo H, Fukushima M.
    Int J Oncol; 2004 Sep 06; 25(3):571-8. PubMed ID: 15289858
    [Abstract] [Full Text] [Related]

  • 7. Cellular basis for the inefficacy of 5-FU in human colon carcinoma.
    Drewinko B, Yang LY.
    Cancer Treat Rep; 1985 Dec 06; 69(12):1391-8. PubMed ID: 4075316
    [Abstract] [Full Text] [Related]

  • 8. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
    Rha SY, Izbicka E, Lawrence R, Davidson K, Sun D, Moyer MP, Roodman GD, Hurley L, Von Hoff D.
    Clin Cancer Res; 2000 Mar 06; 6(3):987-93. PubMed ID: 10741725
    [Abstract] [Full Text] [Related]

  • 9. In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units.
    Marshall MV, Marshall MH, Degen DR, Roodman GD, Kuhn JG, Ross ME, Von Hoff DD.
    Stem Cells; 1993 Jan 06; 11(1):62-9. PubMed ID: 8457783
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic activity of fusaric acid on human adenocarcinoma cells in tissue culture.
    Fernandez-Pol JA, Klos DJ, Hamilton PD.
    Anticancer Res; 1993 Jan 06; 13(1):57-64. PubMed ID: 8476229
    [Abstract] [Full Text] [Related]

  • 11. Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.
    Grem JL, Fischer PH.
    Cancer Res; 1985 Jul 06; 45(7):2967-72. PubMed ID: 4005834
    [Abstract] [Full Text] [Related]

  • 12. Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.
    Fischel JL, Etienne MC, Spector T, Formento P, Renée N, Milano G.
    Clin Cancer Res; 1995 Sep 06; 1(9):991-6. PubMed ID: 9816071
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.
    Saiko P, Horvath Z, Bauer W, Hoechtl T, Grusch M, Krupitza G, Rauko P, Mader RM, Jaeger W, Schott H, Novotny L, Fritzer-Szekeres M, Szekeres T.
    Int J Oncol; 2004 Aug 06; 25(2):357-64. PubMed ID: 15254732
    [Abstract] [Full Text] [Related]

  • 14. Clonogenic patterns of human pulmonary adenocarcinoma cell lines (PC-9, PC-13 and PC-14) and how they influence the results of test for chemosensitivity to cisplatin in the human tumor clonogenic assay.
    Lee YC, Saijo N, Sasaki Y, Takahashi H, Sakurai M, Ishihara J, Hoshi A, Chen KM, Hamburger AW.
    Jpn J Clin Oncol; 1985 Dec 06; 15(4):637-44. PubMed ID: 4094096
    [Abstract] [Full Text] [Related]

  • 15. Expression of Escherichia coli uracil phosphoribosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity.
    Kawamura K, Tasaki K, Hamada H, Takenaga K, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2000 Apr 06; 7(4):637-43. PubMed ID: 10811483
    [Abstract] [Full Text] [Related]

  • 16. Possible link between the intrinsic drug resistance of colon tumors and a detoxification mechanism of intestinal cells.
    Klohs WD, Steinkampf RW.
    Cancer Res; 1988 Jun 01; 48(11):3025-30. PubMed ID: 3365692
    [Abstract] [Full Text] [Related]

  • 17. 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice.
    Saif MW, von Borstel R.
    Cancer Chemother Pharmacol; 2006 Jul 01; 58(1):136-42. PubMed ID: 16187114
    [Abstract] [Full Text] [Related]

  • 18. Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells.
    Arancia G, Calcabrini A, Marra M, Crateri P, Artico M, Martone A, Martelli F, Agostinelli E.
    Amino Acids; 2004 Jun 01; 26(3):273-82. PubMed ID: 15221508
    [Abstract] [Full Text] [Related]

  • 19. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell line.
    Zupi G, Marangolo M, Arancia G, Greco C, Laudonio N, Iosi F, Formisano G, Malorni W.
    Cancer Res; 1988 Nov 01; 48(21):6193-200. PubMed ID: 3167866
    [Abstract] [Full Text] [Related]

  • 20. Human TNF mutants with selective activity on the p55 receptor.
    Van Ostade X, Vandenabeele P, Everaerdt B, Loetscher H, Gentz R, Brockhaus M, Lesslauer W, Tavernier J, Brouckaert P, Fiers W.
    Nature; 1993 Jan 21; 361(6409):266-9. PubMed ID: 8380906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.